⌕
Hyperion Defi · HYPD · Nasdaq
Tenet 56 · Mixed
Compare
$2.47−4.26%At closeTenet 56 · Mixed
$2.47−0.11 (−4.26%)
At close: Nov 16, 2026, 4:00 PM ET· Nasdaq · USD

Hyperion Defi (HYPD) Stock

Hyperion Defi (HYPD) closed at $2.47 on Nov 16, 2026; its Tenet Score is 56 of 100 against 409 Healthcare peers.

Sources Company filings, market prices and computed by Tenet Filings, prices and TenetScore as of How we compute thisNot investment advice

Key stats

Previous close
$2.47
Nov 16, 2026
Market cap
$38.3M
share price × the latest quarter's diluted weighted-average share count (vendor)
52-week range
2.34 – 5.63
low → high
Tenet Score
56/100
Mixed · 409 Healthcare peers

Industry: Drugs · see every company filed here →

HYPERION DEFI, INC. scores 56/100. Mixed. Strongest on value and quality, growth is the soft spot versus 409 Healthcare peers.

Tenet Score · vs sector

n=409
56/ 100
Mixed
Fundamental composite — rates the business, not the timing.
Each metric's standing vs the company's own record is shown on the Statistics tab.
Value
99
Quality
66
Health
55
Growth
5

Factor grades

Grid rings: 25 · 50 · 75 · 100 percentile
ValueA+QualityCHealthCGrowthFMomentumF
A grade is a label over the shown score. Value/Quality/Health/Growth are sector percentiles; Momentum ranks 12−1 return across the equity universe — a lens, never folded into the Tenet Score.
Show the math →

Price

Loading chart…
P/E
—
Not meaningful: the company made a loss.
P/B
0.3×
cap ÷ Sep 30, 2026 book value, Nov 13, 2026 close
P/S
49.1×
price to fiscal 2025 sales
ROE
37%
TTM through Sep 30, 2026
Operating margin
−5743.5%
fiscal 2025, before interest and tax
Net margin
—
Not reported in the company's filings for this period.
Current ratio
3.76
Sep 30, 2026 balance sheet
Net debt / EBITDA
—
Not meaningful: EBITDA is zero or negative.
EPS CAGR 5y
—
This growth figure starts in a period outside the history your plan includes.
Div yield
—
no yield on file

The whole report, at a glance · every card is a live peek, click any to open the section

About HYPERION DEFI, INC.

Eyenovia, Inc., a clinical stage ophthalmic company, engages in developing therapeutics based on its proprietary microdose array print platform technology. The company focuses on developing clinical microdosing of formulations of ophthalmic pharmaceutical a…

Composite computed Nov 16, 2026 · peer basis: Healthcare (n=409) · every glimpse links to its full section with sources · not investment advice.

ETF exposure

held by 3 US ETFs · top wrappers by weightSee all ETFs holding HYPD →

Similar-sized companies in Drugs

The 10 companies in this industry closest in market cap, as of Nov 13, 2026.

What sector and industry is Hyperion Defi in?

Hyperion Defi is in the Healthcare sector and the Drugs industry.

What is Hyperion Defi's Tenet Score?

Hyperion Defi's Tenet Score is 56 out of 100, ranked against 409 Healthcare peers as of Nov 16, 2026.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.